Across four short, sharp and topical MEDTalks, a vibrant, passionate panel of GPs and an epidemiologist will outline the latest considerations for GPs when deciding which COVID treatment to use, on whom, and...
Join nephrologist, Dr Richard Phoon, to discuss the latest recommendations on diagnosing and managing your patients with CKD.
Eosinophilic oesophagitis (EoE) is a differential diagnosis in adults presenting with symptoms of oesophageal dysfunction, such as difficulty or pain when swallowing.
This 1.5-hour educational module explores how to identify affected patients with a family history of cancer and provides an overview of how Familial Cancer Centres can assist these patients through genetic...
In this clinical audit you will conduct a review of patients with pancreatic exocrine insufficiency (PEI) who are currently receiving PERT (pancreatic enzyme replacement therapy), in order to assess their...
In this clinical audit you will review the management of patients with type 2 diabetes and overweight or obesity.

The rising health threat of liver disease: What GPs can do to prevent premature mortality

Liver disease now affects up to 3 of every 10 Australian adults. Primary liver cancer is the most rapidly rising cause of cancer death. Health promotion, prevention, proactive case-finding, early identification of progressive liver fibrosis and early treatment of liver diseases are essential to prevent premature mortality. Learn how to identify, manage and support your patients with liver disease.

Dementia risk reduction: Applying the evidence to optimise your patients' brain health - On-demand webinar

In this on-demand webinar, Dr Hilton Koppe, Dr Marita Long and Prof Kaarin Anstey explore the latest evidence to assess dementia risk, and apply the latest clinical guidelines to help prevent or delay the onset of dementia in your patients. Through a case-based approach, the speakers discuss how the MBS-supported 45-49 year health assessment can be utilised as a timely and effective opportunity for conducting a brain health check.

Long-acting injectable buprenorphine for the treatment of opioid dependence

Module 1 of 2: This learning module explores the nature of opioid dependence and the diagnostic criteria for opioid use disorder, then outlines the use of pharmacotherapies in medication assisted treatment of opioid dependence (MATOD) and the benefits of opioid agonist treatment including long-acting injectable buprenorphine (LAIB) products.

Practical use of long-acting injectable buprenorphine for the treatment of opioid dependence

Module 2 of 2: This two-part activity provides education on the various long-acting buprenorphine (LAIB) formulations available in Australia, followed by a practical exercise where the learner goes through the steps of assessing whether a patient is suitable for LAIB treatment, and discusses with them how treatment may help them achieve their goals.

Dementia in primary care: Recognising and managing behavioural and psychological symptoms and physical comorbidities

Behavioural and psychological symptoms of dementia (BPSD) can lead to quality of life impacts in not only the individual with dementia, but also others around them. This module explores the assessment of BPSD using the ABC (antecedent, behaviour, consequence) model, and discusses the management of BPSD using pharmacological and non-pharmacological methods as well as the management of comorbid conditions associated with dementia.

Pages